Ars Investment Partners, LLC Nemaura Medical Inc. Transaction History

Ars Investment Partners, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 25, 2023	SELL	$1.72 - $3.13 $4,972 - $9,048	-2,891 Reduced 3.56%	78,269 $0
Q3 2022 Oct 07, 2022	SELL	$1.52 - $2.57 $8,688 - $14,690	-5,716 Reduced 6.58%	81,160 $169,000
Q2 2022 Jul 15, 2022	BUY	$2.53 - $4.42 $24,917 - $43,532	9,849 Added 12.79%	86,876 $223,000
Q1 2022 May 16, 2022	BUY	$3.78 - $4.66 $57,319 - $70,664	15,164 Added 24.51%	77,027 $337,000
Q4 2021 Feb 11, 2022	BUY	$4.12 - $6.35 $81,571 - $125,723	19,799 Added 47.07%	61,863 $282,000
Q3 2021 Nov 05, 2021	BUY	$5.76 - $9.95 $55,428 - $95,748	9,623 Added 29.66%	42,064 $253,000
Q2 2021 Aug 06, 2021	SELL	$4.7 - $16.7 $103,780 - $368,752	-22,081 Reduced 40.5%	32,441 $336,000
Q1 2021 May 13, 2021	BUY	$3.79 - $9.78 $206,638 - $533,225	54,522 New	54,522 $417,000

Ticker NMRD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,102,900
Description
Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. It provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes...

Get notified when there are updates to the investment portfolio of Ars Investment Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Ars Investment Partners, LLC with notifications on news.